Trademark Search
Owners
Bristol-Myers Squibb Company
ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL
no statement of use filed
on 09 Sep 2013
Last Applicant/ Owned by
345 Park Avenue
New York
NY
10154
Serial Number
85382237 filed on 27th Jul 2011
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
BRISTOL-MYERS SQUIBB COMPANY
TRADEMARKS DEPT. - MAILSTOP D33-05
P.O. BOX 4000
PRINCETON NJ 08648-4000
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL"
The wording "ABATACEPT" and "METHOTREXATE" has no meaning in a foreign language. "ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL" Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
No 85382237
No Service Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 09th Sep 2013 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 09th Sep 2013 | ABANDONMENT - NO USE STATEMENT FILED |
| 12th Mar 2013 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 17th Jan 2013 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 15th Jan 2013 | TEAS EXTENSION RECEIVED |
| 15th Jan 2013 | EXTENSION 1 GRANTED |
| 15th Jan 2013 | EXTENSION 1 FILED |
| 07th Aug 2012 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 12th Jun 2012 | PUBLISHED FOR OPPOSITION |
| 12th Jun 2012 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
